Modulated serum activities and concentrations of paraoxonase in high density lipoprotein deficiency states. (Q47703029)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9699894%20AND%20SRC:MED&resulttype=core&format=json

2 December 2019

title

Modulated serum activities and concentrations of paraoxonase in high density lipoprotein deficiency states (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9699894%20AND%20SRC:MED&resulttype=core&format=json

2 December 2019

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9699894%20AND%20SRC:MED&resulttype=core&format=json

2 December 2019

Marja-Riitta Taskinen

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9699894%20AND%20SRC:MED&resulttype=core&format=json

2 December 2019

Guido Franceschini

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9699894%20AND%20SRC:MED&resulttype=core&format=json

2 December 2019

author name string

R W James

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9699894%20AND%20SRC:MED&resulttype=core&format=json

2 December 2019

M C Blatter Garin

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9699894%20AND%20SRC:MED&resulttype=core&format=json

2 December 2019

R Miccoli

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9699894%20AND%20SRC:MED&resulttype=core&format=json

2 December 2019

A von Eckardstein

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9699894%20AND%20SRC:MED&resulttype=core&format=json

2 December 2019

M Tilly-Kiesi

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9699894%20AND%20SRC:MED&resulttype=core&format=json

2 December 2019

G Assmann

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9699894%20AND%20SRC:MED&resulttype=core&format=json

2 December 2019

publication date

1 July 1998

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9699894%20AND%20SRC:MED&resulttype=core&format=json

2 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9699894%20AND%20SRC:MED&resulttype=core&format=json

2 December 2019

volume

139

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9699894%20AND%20SRC:MED&resulttype=core&format=json

2 December 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9699894%20AND%20SRC:MED&resulttype=core&format=json

2 December 2019

page(s)

77-82

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9699894%20AND%20SRC:MED&resulttype=core&format=json

Paraoxonase prevents accumulation of lipoperoxides in low-density lipoprotein

2 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900058-6

Protective effect of high density lipoprotein associated paraoxonase. Inhibition of the biological activity of minimally oxidized low density lipoprotein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900058-6

Gln-Arg192 polymorphism of paraoxonase and coronary heart disease in type 2 diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900058-6

A variant of human paraoxonase/arylesterase (HUMPONA) gene is a risk factor for coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900058-6

Paraoxonase polymorphism (Gln192-Arg) is associated with coronary heart disease in Japanese noninsulin-dependent diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900058-6

Genetic polymorphism of paraoxonase and the risk of coronary heart disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900058-6

The Gln-Arg191 polymorphism of the human paraoxonase gene (HUMPONA) is not associated with the risk of coronary artery disease in Finns

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900058-6

The Gln/Arg polymorphism of human paraoxonase (PON 192) is not related to myocardial infarction in the ECTIM Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900058-6

Identification of a distinct human high-density lipoprotein subspecies defined by a lipoprotein-associated protein, K-45. Identity of K-45 with paraoxonase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900058-6

Apolipoprotein J is associated with paraoxonase in human plasma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900058-6

Quantification of human serum paraoxonase by enzyme-linked immunoassay: population differences in protein concentrations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900058-6

Absence of "A"-esterase activity in the serum of a patient with Tangier disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900058-6

Distinction between 'A'-esterases and arylesterases. Implications for esterase classification

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900058-6

Tangier disease: a disorder of intracellular membrane traffic

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900058-6

Compound heterozygosity for a structural apolipoprotein A-I variant, apo A-I(L141R)Pisa, and an apolipoprotein A-I null allele in patients with absence of HDL cholesterol, corneal opacifications, and coronary heart disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900058-6

ApoA-IHelsinki (Lys107-->0) associated with reduced HDL cholesterol and LpA-I:A-II deficiency

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900058-6

A-IMilano apoprotein. Decreased high density lipoprotein cholesterol levels with significant lipoprotein modifications and without clinical atherosclerosis in an Italian family

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900058-6

A-Imilano apoprotein. Isolation and characterization of a cysteine-containing variant of the A-I apoprotein from human high density lipoproteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900058-6

Paraoxonase polymorphism Met-Leu54 is associated with modified serum concentrations of the enzyme. A possible link between the paraoxonase gene and increased risk of cardiovascular disease in diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900058-6

Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900058-6

Immunoaffinity fractionation of high-density lipoprotein subclasses 2 and 3 using anti-apolipoprotein A-I and A-II immunosorbent gels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900058-6

The distribution profiles of very low density and low density lipoproteins in poorly-controlled male, type 2 (non-insulin-dependent) diabetic patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900058-6

The molecular basis of the human serum paraoxonase activity polymorphism.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900058-6

Serum paraoxonase activity, concentration, and phenotype distribution in diabetes mellitus and its relationship to serum lipids and lipoproteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900058-6

The separation of sheep and human serum "A"-esterase activity into the lipoprotein fraction by ultracentrifugation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900058-6

HDL, its enzymes and its potential to influence lipid peroxidation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900058-6

Early incorporation of cell-derived cholesterol into pre-beta-migrating high-density lipoprotein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900058-6

Reverse cholesterol transport in plasma of patients with different forms of familial HDL deficiency

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900058-6

Lipoproteins containing apolipoprotein A-IV but not apolipoprotein A-I take up and esterify cell-derived cholesterol in plasma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900058-6

Reconsideration of the catalytic center and mechanism of mammalian paraoxonase/arylesterase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900058-6